ENDOCRINOLOGIC & METABOLIC DRUGS ADVISORY COMMITTEE

July 26, 2001

Symlin® NDA 21-332,  Aylin Pharmaceuticals

Slides

Overview, Joann L Data, MD, PhD, Amylin Pharmaceuticals, Inc.   ppt   htm

Efficacy, Robert I Misbin, MD, FDA   ppt   htm

Pramlintide Acetate, Safety Review, Dragos Roman, MD, FDA   ppt   htm